Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy

Freek W A Verheugt; Peter Clemmensen; Roxana Mehran; Stefan Agewall; Stuart J Pocock; Sidney Goldstein; Christian Torp-Pedersen; Maarten L Simoons; Jeffrey S Borer; Yasser M Khder; Paul Burton; Efthymios Deliargyris; John J V McMurray; Scott D Berkowitz; Wendy Gattis Stough; Faiez Zannad

doi:10.1093/eurheartj/eht013

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy

Freek W A Verheugt, Peter Clemmensen, Roxana Mehran, Stefan Agewall, Stuart J Pocock, Sidney Goldstein, Christian Torp-Pedersen, Maarten L Simoons, Jeffrey S Borer, Yasser M Khder, Paul Burton, Efthymios Deliargyris, John J V McMurray, Scott D Berkowitz, Wendy Gattis Stough, Faiez Zannad

10 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	European Heart Journal
Vol/bind	34
Udgave nummer	22
Sider (fra-til)	1621-9
Antal sider	9
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/eht013
Status	Udgivet - jun. 2013

Adgang til dokumentet

10.1093/eurheartj/eht013

Citationsformater

Verheugt, F. W. A., Clemmensen, P., Mehran, R., Agewall, S., Pocock, S. J., Goldstein, S., Torp-Pedersen, C., Simoons, M. L., Borer, J. S., Khder, Y. M., Burton, P., Deliargyris, E., McMurray, J. J. V., Berkowitz, S. D., Stough, W. G., & Zannad, F. (2013). Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. European Heart Journal, 34(22), 1621-9. https://doi.org/10.1093/eurheartj/eht013

Verheugt, FWA, Clemmensen, P, Mehran, R, Agewall, S, Pocock, SJ, Goldstein, S, Torp-Pedersen, C, Simoons, ML, Borer, JS, Khder, YM, Burton, P, Deliargyris, E, McMurray, JJV, Berkowitz, SD, Stough, WG & Zannad, F 2013, 'Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy', European Heart Journal, bind 34, nr. 22, s. 1621-9. https://doi.org/10.1093/eurheartj/eht013

@article{ecb2a657d7bf42d7a3927a36d1ac7459,

title = "Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy",

keywords = "Acute Coronary Syndrome, Clinical Trials as Topic, Factor Xa, Fibrinolytic Agents, Forecasting, Hemorrhage, Humans, Patient Safety, Purinergic P2Y Receptor Antagonists, Risk Factors, Treatment Outcome",

author = "Verheugt, {Freek W A} and Peter Clemmensen and Roxana Mehran and Stefan Agewall and Pocock, {Stuart J} and Sidney Goldstein and Christian Torp-Pedersen and Simoons, {Maarten L} and Borer, {Jeffrey S} and Khder, {Yasser M} and Paul Burton and Efthymios Deliargyris and McMurray, {John J V} and Berkowitz, {Scott D} and Stough, {Wendy Gattis} and Faiez Zannad",

year = "2013",

month = jun,

doi = "10.1093/eurheartj/eht013",

language = "English",

volume = "34",

pages = "1621--9",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "22",

}

TY - JOUR

T1 - Antithrombotic outcome trials in acute coronary syndromes

T2 - seeking the optimal balance between safety and efficacy

AU - Verheugt, Freek W A

AU - Clemmensen, Peter

AU - Mehran, Roxana

AU - Agewall, Stefan

AU - Pocock, Stuart J

AU - Goldstein, Sidney

AU - Torp-Pedersen, Christian

AU - Simoons, Maarten L

AU - Borer, Jeffrey S

AU - Khder, Yasser M

AU - Burton, Paul

AU - Deliargyris, Efthymios

AU - McMurray, John J V

AU - Berkowitz, Scott D

AU - Stough, Wendy Gattis

AU - Zannad, Faiez

PY - 2013/6

Y1 - 2013/6

KW - Acute Coronary Syndrome

KW - Clinical Trials as Topic

KW - Factor Xa

KW - Fibrinolytic Agents

KW - Forecasting

KW - Hemorrhage

KW - Humans

KW - Patient Safety

KW - Purinergic P2Y Receptor Antagonists

KW - Risk Factors

KW - Treatment Outcome

U2 - 10.1093/eurheartj/eht013

DO - 10.1093/eurheartj/eht013

M3 - Journal article

C2 - 23382466

SN - 0195-668X

VL - 34

SP - 1621

EP - 1629

JO - European Heart Journal

JF - European Heart Journal

IS - 22

ER -